Abstract:Although respiratory viral infections have been associated with acute rejection and bronchiolitis obliterans syndrome, the long-term impact of the novel pandemic influenza A (2009 H1N1) virus on lung transplant patients has not been defined. We describe the diagnostic challenges and longterm consequences of 2009 H1N1 infection in a lung transplant patient, discuss the potential implications for prevention and treatment, and conclude that even timely antiviral therapy may be insufficient to prevent long-term mo… Show more
“…Other case reports underline the lack of data concerning the long-term pulmonary allograft function as a response to H1N1 infection. Fast establishment of H1N1 diagnosis and preemptive early treatment has been suggested to be important for individuals after lung transplantation [36].…”
Section: Other Viral Pathogens In Lung Transplant Recipientsmentioning
Pharmacological immune suppression, the genetic makeup of the patient as well as concurrent viral infections impact on the successful outcome of lung transplantation and call for more detailed immune-guided diagnostics and therapy.
“…Other case reports underline the lack of data concerning the long-term pulmonary allograft function as a response to H1N1 infection. Fast establishment of H1N1 diagnosis and preemptive early treatment has been suggested to be important for individuals after lung transplantation [36].…”
Section: Other Viral Pathogens In Lung Transplant Recipientsmentioning
Pharmacological immune suppression, the genetic makeup of the patient as well as concurrent viral infections impact on the successful outcome of lung transplantation and call for more detailed immune-guided diagnostics and therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.